Israel vs Latin America & Caribbean: Immunization, Hib3

Israel
98.0%
in 2024
Latin America & Caribbean
81.8%
in 2024
Israel rank
20th
Latin America & Caribbean rank
22nd

Immunization, Hib3 over time

  • Israel
  • Latin America & Caribbean
020406080100199020072024

How they compare

Israel currently reports 98.0% against 81.8% in Latin America & Caribbean, a difference of 16.2%.

That makes Israel's figure about 1.2 times Latin America & Caribbean's.

Across all 31 years both countries report, Israel has been ahead every year.

Israel ranks 20th and Latin America & Caribbean ranks 22nd of 191 countries.

Israel has averaged higher in every one of the 4 decades both report.

Head to head by decade

Decade Israel Latin America & Caribbean Difference Ahead
1990s 92.7% 5.6% 87.1% Israel
2000s 93.8% 84.3% 9.5% Israel
2010s 95.7% 88.0% 7.7% Israel
2020s 98.0% 79.0% 19.0% Israel

Averages of every year both report within each decade.

Frequently asked questions

Which has higher immunization, hib3, Israel or Latin America & Caribbean?
Israel, at 98.0% against 81.8% in Latin America & Caribbean as of 2024.
What is the difference in immunization, hib3 between Israel and Latin America & Caribbean?
16.2%, with Israel ahead.
How many years of comparable data are there for Israel and Latin America & Caribbean?
31 years are reported by both, from 1994 to 2024.
How do Israel and Latin America & Caribbean rank globally for immunization, hib3?
Israel ranks 20th and Latin America & Caribbean ranks 22nd of 191 countries.
Where does this data come from?
WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Israel vs Latin America & Caribbean: Immunization, Hib3. Statizoid, drawing on WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Retrieved 18 September 2026, from https://health.statizoid.com/compare/immunization-hib3-percent-of-children-ages-12-23-months/israel/latin-america-and-caribbean/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/immunization-hib3-percent-of-children-ages-12-23-months/israel/latin-america-and-caribbean/">Israel vs Latin America & Caribbean: Immunization, Hib3</a> — Statizoid

About this data

Indicator
Immunization, Hib3 (% of children ages 12-23 months)
Unit
% of children ages 12-23 months
Source
WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
234 places, 5,441 data points, 1990–2024
Last refreshed

Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.